F-star Therapeutics, Inc.

Ownership Transactions Reported by 11 Insiders

Location
35 Parkwood Drive, Babraham Research Campus, Cambridge, United Kingdom

There are no Buy or Sell transactions made by insiders since 9/12/2023

F-star Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Todd C. Brady Director Jun 17, 2022
Nessan Bermingham Director Mar 8, 2023
Pamela M. Klein Director Jun 17, 2022
Patrick Johan Hendrik Krol Director Jun 4, 2021
Louis Kayitalire Chief Medical Officer Mar 8, 2023
Neil Brewis Chief Scientific Officer Mar 8, 2023
David Arkowitz Director Jun 17, 2022
Geoffrey Race Director Mar 8, 2023
Edward Benz JR Director Mar 8, 2023
Eliot Forster PRESIDENT AND CEO, Director Mar 8, 2023
Darlene Deptula Hicks Treasurer And Chief Financial Officer Mar 8, 2023

Recent Insider Transactions by Companies or Individuals for F-star Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.